CBI Co. Ltd (013720) - Cash Flow Conversion Efficiency
Based on the latest financial reports, CBI Co. Ltd (013720) has a cash flow conversion efficiency ratio of -0.022x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-1.47 Billion ≈ $-993.61K USD) by net assets (₩66.45 Billion ≈ $45.03 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how leveraged is CBI Co. Ltd's balance sheet to measure how much of total assets are equity-financed.
CBI Co. Ltd - Cash Flow Conversion Efficiency Trend (2014–2024)
This chart illustrates how CBI Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 013720 cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
CBI Co. Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of CBI Co. Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
GT Biopharma Inc
NASDAQ:GTBP
|
-0.326x |
|
Horseshoe Metals Ltd
AU:HOR
|
0.151x |
|
Hancom MDS Inc
KQ:086960
|
0.040x |
|
i2S SA
PA:ALI2S
|
0.169x |
|
COCRYSTAL PHARMA NEW O.N.
F:8CC
|
-0.274x |
|
TARGETSPOT S.A. EO 1
F:6YW
|
N/A |
|
Salutica Bhd
KLSE:0183
|
-0.102x |
|
Vesuvius PLC
LSE:VSVS
|
0.074x |
Annual Cash Flow Conversion Efficiency for CBI Co. Ltd (2014–2024)
The table below shows the annual cash flow conversion efficiency of CBI Co. Ltd from 2014 to 2024. For the full company profile with market capitalisation and key ratios, see 013720 stock market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩58.30 Billion ≈ $39.51 Million |
₩4.00 Billion ≈ $2.71 Million |
0.069x | -37.02% |
| 2023-12-31 | ₩51.92 Billion ≈ $35.19 Million |
₩5.65 Billion ≈ $3.83 Million |
0.109x | +445.75% |
| 2022-12-31 | ₩42.63 Billion ≈ $28.89 Million |
₩-1.34 Billion ≈ $-909.71K |
-0.031x | +81.49% |
| 2021-12-31 | ₩30.17 Billion ≈ $20.44 Million |
₩-5.13 Billion ≈ $-3.48 Million |
-0.170x | -224.66% |
| 2020-12-31 | ₩19.85 Billion ≈ $13.45 Million |
₩-1.04 Billion ≈ $-705.03K |
-0.052x | -142.03% |
| 2019-12-31 | ₩21.98 Billion ≈ $14.90 Million |
₩2.74 Billion ≈ $1.86 Million |
0.125x | +63.89% |
| 2018-12-31 | ₩21.38 Billion ≈ $14.49 Million |
₩1.63 Billion ≈ $1.10 Million |
0.076x | -35.58% |
| 2017-12-31 | ₩20.41 Billion ≈ $13.83 Million |
₩2.41 Billion ≈ $1.63 Million |
0.118x | +119.77% |
| 2016-12-31 | ₩20.30 Billion ≈ $13.76 Million |
₩1.09 Billion ≈ $739.20K |
0.054x | -62.98% |
| 2015-12-31 | ₩18.33 Billion ≈ $12.42 Million |
₩2.66 Billion ≈ $1.80 Million |
0.145x | -22.83% |
| 2014-12-31 | ₩16.47 Billion ≈ $11.16 Million |
₩3.10 Billion ≈ $2.10 Million |
0.188x | -- |
About CBI Co. Ltd
CBI Co., Ltd. manufactures and sells car parts in South Korea. Its products include valve tappets, hydraulic tensioner housings, fixture injectors, TM parts, levers, Eegr base products, insert chambers, valve seat rings, piece an engagement product, and bearing journals. The company was founded in 1959 and is headquartered in Incheon, South Korea.